Last Updated: 10 Apr 2020 08:19 AM

India Top Stories

 Economic times

 getmoneyrich.com

 goodreturns.com

 moneyexcel.com

 equitymaster.com

  • Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark


    Indian share markets�witnessed buying interest throughout the day and ended on a strong note.

    Benchmark indices rose over 4% today, as strong global cues and expectations of further stimulus measures from the Indian government as well as central bankers across the world boosted sentiment.

    At the closing bell, the�BSE Sensex�stood higher by 1,266 points (up 4.2%) and the�NSE Nifty�closed higher by 354 points (up 4%).

    The�BSE Mid Cap index�ended up by 3.6%, while the�BSE Small Cap index�ended the day up by 3.2%.

    On the sectoral front, gains were largely seen in the automobile sector, consumer durables sector and finance sector.

    Asian stock markets�finished on a positive note as of the most recent closing prices. The�Hang Seng�was up 1.3% and the Shanghai Composite stood higher by 0.4%.

    The rupee was trading at 76.30 to the US$ at the time of writing.

    --- Advertisement ---
    The Biggest Opportunity Available Right Now

    Today, coronavirus crisis has created a lot of fear and uncertainty.

    But amid this fear and chaos... there is one thing which is certain.

    As soon as the fears of coronavirus abate... there would be a massive rally in the stock markets.

    You won't be able to grab the stocks... which are available at a throw away prices today.

    This is the time to start loading up on fundamentally strong stocks.

    Because the returns that one could potentially make from these prices could be mind-boggling.

    Potentially Rs 1 crore or more in the long run.

    And we've already shortlisted one stock having that potential.

    Click here to know more about this stock
    ------------------------------

    The�rupee�fell to a new record low against the US dollar today, despite strong domestic equity markets.

    The domestic currency opened at 76.10 before sliding to a record low of 76.55 against the US$.

    In the previous session, the rupee had depreciated 70 paise to its life-time low of 76.34 as a rise in coronavirus cases fanned fears of the government extending the lockdown to contain the pandemic.

    Speaking of Indian share markets, in the article titled�How Corona Crash Hit Indian Financial Markets in March 2020 - 6 Charts, we dive deeper and look at how Indian financial markets performed in March 2020.

    Also, speaking of the current stock market scenario, stock markets around the world witnessed one of the most painful correction phases in the month of March 2020.

    Indian stock markets�too mirrored the trend. In the month of March 2020, the�Sensex�fell as much as 23%.

    At times like these, while we must do everything we can to guard against the coronavirus, we must not ignore our money.

    Our special report,�How to Trade the Coronavirus Crash, will help you get a grip on the current market situation...and figure out ways to profit from it.

    This is the most comprehensive report on how to trade the coronavirus, both from a short-term and long-term perspective.�Claim your FREE copy here...

    And rest assured,�Equitymaster�is with you all the way on this journey. To that end, we have decided to offer you two of our premium learning courses free!

    From the comfort of your home, you can learn the basics of fundamental investing with�Equitymaster Secrets and the ins and outs of making money using derivatives with�Derivantage.�Get started right away.

    In news from the commodity space, international gold prices rose today ahead of a US weekly jobless claims report.

    Gold prices in India traded marginally higher with June futures rising 0.6% to Rs 45,235 per 10 grams.

    --- Advertisement ---
    This Lockdown Become a Pro Investor...FREE

    We have great news for you.

    For the duration of the lockdown – we are giving everybody completely free access to our two most popular learning courses.

    Equitymaster's Secrets– an online course that will reveal the complete process behind our own stock–picking strategy.

    DeriVantage – an online course that will teach you to trade derivatives – and develop your own trading strategy to create short–term and long–term wealth.

    This is a one–time opportunity...with no strings attached. Access is absolutely free – no credit card required.

    Just click below and we will instantly activate your free access to either or both courses.

    Click Here for Free Access: Equitymaster's Secrets | DeriVantage
    ------------------------------

    In other news, data from the World Gold Council (WGC) showed that gold-backed exchange traded funds (ETFs) witnessed a net inflow of US$ 23 billion, or 298 tonnes, in the January-March 2020 quarter across all regions.

    This is the highest quarterly amount ever in absolute US dollar terms and the largest tonnage additions since 2016.

    During the past year,�gold�ETFs added 659 tonnes, the highest on a rolling annual basis since the financial crisis, with assets under management (AUM) growing 57% over the same period.

    Globally,�gold ETFs�recorded a net inflows of US$ 8.1 billion in March 2020 and added 151 tonnes, taking the total holding to new all-time high of 3,185 tonnes.

    European funds led regional inflows in March 2020, surging 84 tonnes, while North American funds added 57 tonnes.

    Asian funds, primarily in China also finished the month with strong inflows, adding 4.9 tonnes.

    However, India witnessed a negative flow of US$ 16.4 million during this period.

    Speaking of gold, you will be surprised to know that�the safe haven has�outperformed equities over a 15-year period.

    Have a look at the chart below:

    An equal amount of Rs 100 invested in both gold and Sensex in 2004 would have generated higher returns in gold by a wide margin.

    Your total investment in gold and Sensex would be valued at Rs 687 and Rs 410, respectively.

    So, investors in gold are happier than investors in Sensex or equities at this moment.

    Moving on to news from the pharma space, shares of Cipla surged 15% today after it received United States Food and Drug Administration's (USFDA) nod for the first generic Proventil HFA (albuterol sulfate) metered dose inhaler, used for conditions such as asthma.

    This is the first AB-rated generic therapeutic equivalent version of Merck Sharp & Dohme Corp's Proventil HFA Inhalation Aerosol. It is used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms.

    Proventil HFA Inhalation Aerosol and its authorized generic equivalent had US sales of approximately US$ 153 million for the 12-month period ending February 2020, according to IQVIA (IMS Health).

    Cipla share price ended the day up by 13.2%.

    In other news, Sun Pharma share price was also in focus today. Stock of the company ended higher for the fourth consecutive day today.

    With this sharp rally, Sun Pharma regained the market-capitalisation of Rs 1-trillion.

    Speaking of the pharma sector, in December 2019, co-head of Research at Equitymaster, Tanushree Banerjee had predicted that pharma could be the sector to see a big rebound in 2020.

    And rightly so, most pharma companies have re-emerged as the safer bets for investors in the ongoing market turmoil. The Indian rupee touched a new record low of Rs 76.55 against the US dollar today. Most�pharma companies�generate their revenues through exports. Hence, a depreciating rupee is a positive development for them.

    As per Tanushree, in a post Covid-19 world, healthcare expenditures globally will see a big rejig.

    The world needs affordable medicines in large quantities. Very few can supply them in the quantity and cost that Indian drug makers can. Yet, most�Indian pharma�stocks are trading at historically low valuations.

    Tanushree is recommending her subscribers, to buy stocks selectively, a few at a time, by taking partial exposures to begin with.

    She has already recommended 4 safe bluechips in the past month and there are several more in her watchlist. You can access them here:�Here's How You Could Trade the Coronavirus Crisis Safely�(requires subscription).

    And if you are not a StockSelect subscriber,�here's where you sign up.

    To know what's moving the Indian stock markets today, check out the most recent�share market updates here.



    This article (Sensex Surges 1,266 Points; Nifty Ends Above 9,100 Mark) is authored by Equitymaster.

    Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

  • VOLTAS Surges by 6%; BSE CAPITAL GOODS Index Up 1.6%


    VOLTAS share price has zoomed 6% and is presently trading at Rs 515.

    Meanwhile, the BSE CAPITAL GOODS Index is at 11,313 (up 1.6%).

    Among the top Gainers in the BSE CAPITAL GOODS Index today are VOLTAS (up 6.0%) and HEG (up 10.0%).

    THERMAX (down 0.6%) and KALPATARU POWER (down 0.6%) are among the top losers today.

    Over the last one year, VOLTAS has moved down from Rs 611 to Rs 515, registering a loss of Rs 96 (down 16.4%).

    On the other hand, the BSE CAPITAL GOODS has moved down from 18,367 to 11,313, loss of 7,054 points (down 39.0%) during the last 12 months.

    The top gainers among the BSE CAPITAL GOODS Index stocks during this same period were HONEYWELL AUTOMATION (up 20.0%) and SIEMENS (up 0.8%).

    One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

    What About the Benchmark Indices?

    The BSE Sensex is at 31,225 (up 4.1%).

    The top gainers among the BSE Sensex stocks today are M&M (up 17.0%), MARUTI SUZUKI (up 12.9%) and TITAN (up 11.3%). Other gainers include HDFC (up 9.5%) and BAJAJ FINANCE (up 9.0%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

    In the meantime, NSE Nifty is at 9,128 (up 4.0%). The top gainers in the NSE Nifty include M&M (up 17.2%), MARUTI SUZUKI (up 13.9%) and CIPLA (up 13.1%). Other gainers include TITAN (up 11.2%) and TATA MOTORS (up 10.4%) are among the top gainers in NSE Nifty.

    Over the last 12 months, the BSE Sensex has moved down from 38,701 to 31,225, registering a loss of 7,476 points (down 19.59%).

    VOLTAS Financial Update...

    VOLTAS net profit down at Rs 1 billion for the quarter ended December 2019, compared to a loss of Rs 1 billion a year ago. Net Sales rose 0.0% to Rs 14.9 billion during the period as against Rs 14.9 billion in October-December 2018.

    For the year ended March 2019, VOLTAS reported 0.7% increase in net profit to Rs 5.8 billion compared to net profit of Rs 5.7 billion during FY18.

    Revenue of the company grew 10.8% to Rs 71 billion during FY19.

    The current Price to earnings ratio of VOLTAS, based on rolling 12 month earnings, stands at 29.6x.

    This article (VOLTAS Surges by 6%; BSE CAPITAL GOODS Index Up 1.6%) is authored by Equitymaster.

    Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

  • MARUTI SUZUKI Surges by 13%; BSE AUTO Index Up 10.2%


    MARUTI SUZUKI share price has zoomed 13% and is presently trading at Rs 5,399.

    Meanwhile, the BSE AUTO Index is at 12,733 (up 10.2%).

    Among the top Gainers in the BSE AUTO Index today are MARUTI SUZUKI (up 12.9%) and MRF LTD. (up 5.2%).

    Over the last one year, MARUTI SUZUKI has moved down from Rs 7,120 to Rs 5,399, registering a loss of Rs 1,721 (down 25.5%).

    On the other hand, the BSE AUTO has moved down from 19,228 to 12,733, loss of 6,495 points (down 34.3%) during the last 12 months.

    The top gainers among the BSE AUTO Index stocks during this same period were MRF LTD. (up 2.0%).

    One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

    What About the Benchmark Indices?

    The BSE Sensex is at 31,225 (up 4.1%).

    The top gainers among the BSE Sensex stocks today are M&M (up 17.0%), MARUTI SUZUKI (up 12.9%) and TITAN (up 11.3%). Other gainers include HDFC (up 9.5%) and BAJAJ FINANCE (up 9.0%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

    In the meantime, NSE Nifty is at 9,128 (up 4.0%). The top gainers in the NSE Nifty include M&M (up 17.2%), MARUTI SUZUKI (up 13.9%) and CIPLA (up 13.1%). Other gainers include TITAN (up 11.2%) and TATA MOTORS (up 10.4%) are among the top gainers in NSE Nifty.

    Over the last 12 months, the BSE Sensex has moved down from 38,701 to 31,225, registering a loss of 7,476 points (down 19.59%).

    MARUTI SUZUKI Financial Update...

    MARUTI SUZUKI net profit stood at Rs 16 billion for the quarter ended December 2019, compared to a profit of Rs 15 billion a year ago. Net Sales rose 5.3% to Rs 207.1 billion during the period as against Rs 196.7 billion in October-December 2018.

    For the year ended March 2019, MARUTI SUZUKI reported 2.9% decrease in net profit to Rs 76.5 billion compared to net profit of Rs 78.8 billion during FY18.

    Revenue of the company grew 4.9% to Rs 861 billion during FY19.

    The current Price to earnings ratio of MARUTI SUZUKI, based on rolling 12 month earnings, stands at 26.0x.

    This article (MARUTI SUZUKI Surges by 13%; BSE AUTO Index Up 10.2%) is authored by Equitymaster.

    Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

  • LUPIN Surges by 13%; BSE HEALTHCARE Index Up 3.4%


    LUPIN share price has zoomed 13% and is presently trading at Rs 798.

    Meanwhile, the BSE HEALTHCARE Index is at 14,820 (up 3.4%).

    Among the top Gainers in the BSE HEALTHCARE Index today are LUPIN (up 12.7%) and DIVIS LABORATORIES (up 6.2%).

    J.B.CHEMICALS (down 0.2%) and PROCTER & GAMBLE HEALTH (down 1.2%) are among the top losers today.

    Over the last one year, LUPIN has moved up from Rs 792 to Rs 798, registering a gain of Rs 5 (up 0.3%).

    On the other hand, the BSE HEALTHCARE has moved up from 14,273 to 14,820, registering a gain of 547 points (up 1.6%) during the last 12 months.

    The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 145.1%), IPCA LABS (up 70.3%) and ALKEM LABORATORIES (up 53.5%).

    One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

    What About the Benchmark Indices?

    The BSE Sensex is at 31,225 (up 4.1%).

    The top gainers among the BSE Sensex stocks today are M&M (up 17.0%), MARUTI SUZUKI (up 12.9%) and TITAN (up 11.3%). Other gainers include HDFC (up 9.5%) and BAJAJ FINANCE (up 9.0%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

    In the meantime, NSE Nifty is at 9,128 (up 4.0%). The top gainers in the NSE Nifty include M&M (up 17.2%), MARUTI SUZUKI (up 13.9%) and CIPLA (up 13.1%). Other gainers include TITAN (up 11.2%) and TATA MOTORS (up 10.4%) are among the top gainers in NSE Nifty.

    Over the last 12 months, the BSE Sensex has moved down from 38,701 to 31,225, registering a loss of 7,476 points (down 19.59%).

    LUPIN Financial Update...

    LUPIN net profit down at Rs 9 billion for the quarter ended December 2019, compared to a loss of Rs 2 billion a year ago. Net Sales declined 16.3% to Rs 37.7 billion during the period as against Rs 45.0 billion in October-December 2018.

    For the year ended March 2019, LUPIN reported 44.6% decrease in net profit to Rs 9.5 billion compared to net profit of Rs 17.2 billion during FY18.

    Revenue of the company grew 5.8% to Rs 167 billion during FY19.

    The current Price to earnings ratio of LUPIN, based on rolling 12 month earnings, stands at down 87.9x.

    This article (LUPIN Surges by 13%; BSE HEALTHCARE Index Up 3.4%) is authored by Equitymaster.

    Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

  • TATA ELXSI Surges by 11%; BSE IT Index Up 1.6%


    TATA ELXSI share price has zoomed 11% and is presently trading at Rs 712.

    Meanwhile, the BSE IT Index is at 12,890 (up 1.6%).

    Among the top Gainers in the BSE IT Index today are TATA ELXSI (up 11.1%) and FIRSTSOURCE SOL. (up 12.2%).

    TECH MAHINDRA (down 2.4%) is among the top loser today.

    Over the last one year, TATA ELXSI has moved down from Rs 963 to Rs 712, registering a loss of Rs 251 (down 26.6%).

    On the other hand, the BSE IT has moved down from 15,706 to 12,890, loss of 2,816 points (down 18.9%) during the last 12 months.

    One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

    What About the Benchmark Indices?

    The BSE Sensex is at 31,225 (up 4.2%).

    The top gainers among the BSE Sensex stocks today are M&M (up 19.4%), MARUTI SUZUKI (up 14.1%) and TITAN (up 12.5%). Other gainers include BAJAJ FINANCE (up 9.8%) and HERO MOTOCORP (up 9.7%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

    In the meantime, NSE Nifty is at 9,128 (up 4.1%). The top gainers in the NSE Nifty include M&M (up 17.2%), CIPLA (up 13.0%) and MARUTI SUZUKI (up 12.7%). Other gainers include TITAN (up 10.9%) and TATA MOTORS (up 10.0%) are among the top gainers in NSE Nifty.

    Over the last 12 months, the BSE Sensex has moved down from 38,701 to 31,225, registering a loss of 7,476 points (down 19.53%).

    TATA ELXSI Financial Update...

    TATA ELXSI net profit stood at Rs 754 million for the quarter ended December 2019, compared to a profit of Rs 660 million a year ago. Net Sales rose 4.0% to Rs 4.2 billion during the period as against Rs 4.1 billion in October-December 2018.

    For the year ended March 2018, TATA ELXSI reported 37.3% increase in net profit to Rs 2.4 billion compared to net profit of Rs 1.7 billion during FY17.

    Revenue of the company grew 12.0% to Rs 14 billion during FY18.

    The current Price to earnings ratio of TATA ELXSI, based on rolling 12 month earnings, stands at 17.9x.

    This article (TATA ELXSI Surges by 11%; BSE IT Index Up 1.6%) is authored by Equitymaster.

    Equitymaster is a leading 'independent' equity research initiative focused on providing well-researched and unbiased opinions on stocks listed on the Bombay Stock Exchange.

 myinvestmentideas.com

 fundsindia.com

 freefincal

 elearnmarkets.com

 capitalmind.in

 subramoney

 tradebrains.in

 unovest.co

 thecalminvestor.com

 financegab.com